This study, called MATCH-UP, is looking at ways to make cancer care easier for people with breast or prostate cancer. Many people spend a lot of time and money traveling for appointments, so Memorial Sloan Kettering (MSK) wants to reduce the need for in-person visits. They are testing an "Enhanced Telehealth" approach, which includes telehealth visits (appointments by phone or video), home blood draws, and support for giving yourself injection medications at home. You would be compared to patients receiving usual care. The study wants to see if this enhanced telehealth option can reduce the number of routine in-person visits over 12 months. To join, you must be at least 18 years old, have breast or prostate cancer, and have had at least three prior medical oncology visits at MSK. The study is currently unclear on its recruitment status.

Study design

This study is comparing two groups: one receiving usual care and another receiving enhanced telehealth services. It plans to include 1750 participants.

What's involved

Not specified in the trial record.

Compensation

Not stated in the trial record.

Follow-up

The study will measure the proportion of in-person visits over 12 months.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.